Receiving buprenorphine should not be contingent upon receivingcounseling as well, according to a “Dear Colleague” letter issued May 9 bythe Food and Drug Administration (FDA) and the Substance Abuse andMental Health Services Administration (SAMHSA). In the letter, states that“an often-cited barrier to prescribing buprenorphine for the treatment of OUD[opioid use disorder] is … [Read more...] about SAMHSA and FDA reduce counseling recommendations for buprenorphine
What’s happening with all the NPRMs and bills?
Quick summary from AT Forum Confused by all the bills and proposals? That puts you in good company with most of America, except for us nerds who do nothing else. Here’s a quick summary of what’s going on in the methadone (and sometimes, buprenorphine) world, and who’s for what. Regulatory Telemedicine and buprenorphine: The Drug Enforcement Administration is going to … [Read more...] about What’s happening with all the NPRMs and bills?
NABH responds to “cartel” and “profits” comments against OTPs by lawmakers pushing office-based methadone bill
On March 24 the National Association for Behavioral Healthcare (NABH) wrote a blistering letter to the two leaders in charge of a bill which would move methadone treatment beyond opioid treatment programs (OTPs) to include office-based addiction medicine practitioners. The organization expressed its “deep disappointment” with the language used by the lawmakers in official press … [Read more...] about NABH responds to “cartel” and “profits” comments against OTPs by lawmakers pushing office-based methadone bill
Are OTPs cartels? Congressman Norcross says they are
The rhetoric against methadone has reached stunning levels. When Representative Donald Norcross (D-New Jersey) joined the other congressional sponsors of the Modernizing Opioid Treatment Access Act this month, his press statement referred to the opioid treatment program (OTP) model as a “cartel.” The proposed legislation would, like the OTAA proposed last year (see … [Read more...] about Are OTPs cartels? Congressman Norcross says they are
DEA proposes permanent telemedicine flexibilities for buprenorphine and controlled substances
On February 24, Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The proposed rules – developed with the U.S. … [Read more...] about DEA proposes permanent telemedicine flexibilities for buprenorphine and controlled substances